
|Videos|May 20, 2015
What Lessons Have Been Learned from High Cost Hepatitis C Drugs?
Author(s)Davy James, Managing Editor
Marc O'Connor, Chief Operating Officer of Curant Health, discusses the main takeaways from the impact of hepatitis C drugs on specialty pharmacy.
Advertisement
Marc O'Connor, Chief Operating Officer of Curant Health, discusses the main takeaways from the impact of hepatitis C drugs on specialty pharmacy.
This video was recorded courtesy of Armada Health Care at the 2015 Armada Specialty Pharmacy Summit in Las Vegas, Nevada.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 Vaccination in Medically Complex Adults
2
FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myeloma
3
Generic Semaglutide May Make GLP-1 Therapy Cost-Effective in T2D
4
Closing the Calcium Gap: How Pharmacists Can Guide Patients Toward Better Bone Health
5




































































































